IVVD

Invivyd

0.7209

+0.0352+5.13%

After Hours: 0.7299 +0.0090 +1.25%19:55 08/14 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.8883/0.8681

TODAY RANGE0.8883-1.010

VOL7.25M

MARKET CAP282.82M

52 WEEK RANGE0.4830-3.070

AVG VOL (3M)4.41M

% TURNOVER2.45%

TURNOVER--

P/E (TTM)-2.5689

% RANGE14.02%

EPS(TTM)-0.3735

P/E(FORWARD)-1.7134

P/B1.562

BVPS0.6143

DIVIDEND--

P/S5.06

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP244.99M

SHARES OUTSTANDING294.76M

NEXT EARNINGS11/04-11/09

FREE FLOAT255.33M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·1d ago
Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD), Traws Pharma (TRAW) and DocGo (DCGO)
TipRanks·4d ago
Invivyd’s Nasdaq Listing at Risk: Potential Delisting Threatens Financing Access and Market Value
TipRanks·5d ago
Invivyd (IVVD) Gets a Buy from Cantor Fitzgerald
NASDAQ·5d ago
Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates
Dow Jones·6d ago
Press Release: Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
NASDAQ·6d ago
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Beats Revenue Estimates
TipRanks·07/24 20:38
Invivyd Receives Nasdaq Notice for Bid Price Deficiency
TipRanks·07/09 12:40
Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK)
TipRanks·07/08 10:15
Invivyd: Buy Rating Reiterated as PEMGARDA EUA Transition Seen as Administrative; $10 Price Target Unchanged
Dow Jones·07/07 09:48
Invivyd Price Target Maintained With a $10.00/Share by BTIG
Dow Jones·07/06 15:58
FDA to End Emergency Use Authorization For Invivyd's Covid-19 Prevention Shot
Seeking Alpha·07/06 11:36
Invivyd gets notice of Pemgarda EUA termination
TipRanks·07/06 11:28
Invivyd Plans Post-EUA Pathway for PEMGARDA Antibody
TipRanks·07/06 11:20
Invivyd announces notice of termination for Pemgarda Emergency Use Authorization
NASDAQ·06/16 14:09
Invivyd Completes Enrollment In Phase 3 LIBERTY Trial Of VYD2311 For COVID-19

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

+1.09%

869.26

Biogen Inc

BIIB

+1.63%

212.55

Amgen Inc

AMGN

-0.63%

415.21

SHPG

CELG-RT

LLY

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

-2.90%

2.010

Johnson & Johnson

JNJ

+0.83%

262.51

Abbvie Inc

ABBV

-0.54%

249.46

Zoetis Inc

ZTS

+1.36%

73.96

Gilead Sciences Inc

GILD

+0.36%

138.86

Novo-Nordisk A/S

NVO

+1.85%

45.71

Bristol-Myers Squibb Co

BMY

+1.25%

64.63

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-0.04%

26.79

Sanofi FR

SNY

+1.91%

45.83

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+1.70%

154.55

Dr Reddys Labs

RDY

-1.21%

12.27

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.